SKN | Retension Pharmaceuticals Raises $45 Million in Upsized IPO to Advance Hypertension Drug
Retension Pharmaceuticals, a clinical-stage biotechnology company developing a treatment for uncontrolled and resistant hypertension, has raised $45 million in an upsized initial public offering,...
SKN | TRex Bio, Inc. Common Stock: Biotechnology IPO Puts Immune-System Innovation in Focus
TRex Bio, Inc. is a biotechnology company focused on developing therapies that target regulatory pathways in the immune system, placing its business within a...
SKN | Tidal Trust II Broadens ETF Market Access as Demand for Specialized Strategies Increases
Tidal Trust II is an investment fund platform rather than a conventional IPO candidate, meaning there is no single market debut, fundraising target or...
SKN | Haemonetics Stock Surges 17.46% as Medical Technology Shares Rally
Haemonetics Corporation (NYSE: HAE), a medical technology company specializing in blood management and hospital technologies, closed at $119.47 on October 8, 2026, gaining $17.76,...
SKN | Albertsons Stock Rises 5.11% Ahead of Quarterly Earnings Report
Albertsons Companies, Inc. (NYSE: ACI) closed at $12.34 on October 8, 2026, gaining $0.60, or 5.11%, as the grocery retailer advanced ahead of its...